M1FG
BCYC

Mach-1 Financial Group’s Bicycle Therapeutics BCYC Stock Holding History

Mach-1 Financial Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,701
Closed -$496K – 232
2023
Q3 		$496K Buy
+24,701
New +$565K 0.21% 120

Other funds holding BCYC

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Mach-1 Financial Group's BCYC Position: Q4 2023 in Review

Mach-1 Financial Group sold out of Bicycle Therapeutics (BCYC) in Q4 2023, closing a stake of 24,701 shares — an estimated $496K sold.

Mach-1 Financial Group first reported a position in BCYC in Q3 2023 and held it in 1 quarter. The position peaked at $496K in Q3 2023. 101 funds tracked by Wall St. Rank hold BCYC as of Q4 2023.

  • Mach-1 Financial Group reported no remaining Bicycle Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Mach-1 Financial Group sold 24,701 Bicycle Therapeutics shares in Q4 2023, an estimated $496K.
  • Mach-1 Financial Group first reported a position in Bicycle Therapeutics in Q3 2023 and held it in 1 quarter.
  • Mach-1 Financial Group's Bicycle Therapeutics position peaked at $496K in Q3 2023.
  • 101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2023.

Based on Mach-1 Financial Group's 13F filing for Q4 2023, filed 5 Feb 2024.